Angelicin potentiates TRAIL-induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down-regulation of c-FLIP expression

Kyoung Jin Min, Hee Jung Um, Seung Un Seo, Seon Min Woo, Shin Kim, Jong Wook Park, Hyun Shik Lee, Sang Hyun Kim, Yung Hyun Choi, Tae Jin Lee, Taeg Kyu Kwon

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

(Table presented.). Angelicin is a furocoumarin derived from Psoralea corylifolia L. fruit that has anti-inflammatory and anti-tumor activity. In the present study, the effect of angelicin in enhancing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptotic cell death was studied in Caki (renal carcinoma) cells. Angelicin alone and TRAIL alone had no effect on apoptosis, but in combination these compounds markedly induced apoptosis in the cancer cell lines while not inducing apoptosis in normal cells. The combination treatment induced accumulation of the sub-G1 population, DNA fragmentation, and activated caspase 3 activity in Caki cells, induced down-regulation of c-FLIP expression post-translationally, and over-expression of c-FLIP markedly blocked apoptosis induced by combined treatment with angelicin plus TRAIL. This study provides evidence that angelicin might be a TRAIL sensitizer.

Original languageEnglish
Pages (from-to)3-10
Number of pages8
JournalDrug Development Research
Volume79
Issue number1
DOIs
StatePublished - Feb 2018

Keywords

  • TRAIL
  • angelicin
  • apoptosis
  • c-FLIP
  • caspase

Fingerprint

Dive into the research topics of 'Angelicin potentiates TRAIL-induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down-regulation of c-FLIP expression'. Together they form a unique fingerprint.

Cite this